Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea

BACKGROUND: Lenvatinib has been recently approved as a first-line treatment option for patients with unresectable hepatocellular carcinoma (HCC) in Korea. We aimed to study the efficacy and safety of lenvatinib therapy in a real-world practice and to find prognostic factors related to survival and d...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Liver Cancer
Main Authors: Goh, Myung Ji, Oh, Joo Hyun, Park, Yewan, Kim, Jihye, Kang, Wonseok, Sinn, Dong Hyun, Gwak, Geum-Youn, Paik, Yong-Han, Choi, Moon Seok, Lee, Joon Hyeok, Koh, Kwang Cheol, Paik, Seung Woon
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2021
Teme:
Original Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7923940/
https://ncbi.nlm.nih.gov/pubmed/33708639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000512239
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki